Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.65
Delayed Data
As of May 02
 -0.12 / -3.18%
Today’s Change
2.58
Today|||52-Week Range
6.85
+3.11%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close3.77
Today’s open3.76
Day’s range3.53 - 3.78
Volume1,698,054
Average volume (3 months)2,276,787
Market cap$602.7M
Dividend yield5.48%
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-67.32%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.66%
P/E ratio1.8
Price/Sales0.99
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.19-1.16%
CPXXCelator Pharmaceutic...+0.22+1.46%
SRPTSarepta Therapeutics...+3.73+26.29%
EPZMEpizyme Inc+0.25+2.40%
Data as of 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.50
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers

Search for Jobs